Register entry
SHILPA MEDICARE LIMITED
- Registered sites
- 5
- Drug products
- 4
- Live patents
- 15
- Countries
- 1
- Base
- India
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingLabellingFinished drug manufacturePackaging
Sites
Facilities
5| Site | Location | Operations | FEI |
|---|---|---|---|
| SHILPA MEDICARE LIMITED | BengaluruIndia | Analytical testing | 3010619401 |
| SHILPA MEDICARE LIMITED | BengaluruIndia | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3018694237 |
| SHILPA BIOLOGICALS PRIVATE LIMITED | DharwadIndia | Analytical testing, Finished drug manufacture, Packaging | 3022989727 |
| SHILPA MEDICARE LIMITED | HyderabadIndia | Analytical testing | 3019773458 |
| SHILPA MEDICARE LIMITED | MahabubnagarIndia | Analytical testing, Finished drug manufacture, Packaging | 3009876430 |
Exclusivity
Patents
15Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| DOCETAXEL | DOCETAXEL | Aug 2031 |
| DOCETAXEL | DOCETAXEL | Sept 2033 |
| PEMETREXED | PEMETREXED DISODIUM | Mar 2035 |
Catalogue
Marketed products
4Showing 4 of 4.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Bortezomib | Bortezomib | INJECTION | NDA |
| Pemetrexed | Pemetrexed disodium | INJECTION | NDA |
| Pemetrexed | Pemetrexed disodium | INJECTION | NDA |
| Pemetrexed | Pemetrexed disodium | INJECTION | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.